Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 0 | 1 | 1 | 3,239 | 28 |
| Gross Profit | N/A | 1 | 1 | 3,239 | 28 |
| Operating Expenses | 6,534 | 6,610 | 6,098 | 11,413 | 3,466 |
| Operating Income | -6,534 | -6,609 | -6,097 | -8,174 | -3,438 |
| Interest Expense | 0 | 152 | 0 | 0 | 0 |
| Other Income | 23 | 585 | -574 | -2,984 | -592 |
| Pre-tax Income | -6,511 | -6,176 | -6,671 | -11,158 | -4,030 |
| Net Income Continuous | -6,511 | -6,176 | -6,671 | -11,220 | -4,030 |
| Net Income | $-6,511 | $-6,176 | $-6,671 | $-11,220 | $-4,030 |
| EPS Basic Total Ops | -0.73 | -0.86 | -1.06 | 4.91 | -13.32 |
| EPS Basic Continuous Ops | -0.73 | -0.86 | -1.06 | 4.86 | -13.30 |
| EPS Diluted Total Ops | -0.73 | -0.86 | -1.06 | 11.64 | -13.32 |
| EPS Diluted Continuous Ops | -0.73 | -0.86 | -1.06 | 11.60 | -13.30 |
| EBITDA(a) | $-6,438 | $-6,471 | $-5,921 | $-7,950 | $-3,147 |